U. Gatzemeier
- Pulmonary and Respiratory Medicine top 0.05%
- Oncology top 0.05%
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Epidemiology top 5%
- Co-authors
- Joachim von PawelChristian ManegoldE. KaukelPaolo PaolettiFilippo de MarinisGiorgio V. ScagliottiClaude DenhamClet Niyikiza
- Topics
- Lung Cancer Treatments and Mutations (113 papers)Lung Cancer Research Studies (87 papers)Cancer therapeutics and mechanisms (43 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
U. Gatzemeier
180 papers receiving 15.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Pulmonary and Respiratory Medicine 12.3k
- Oncology 10.7k
- Molecular Biology 3.6k
- Cancer Research 1.8k
- Epidemiology 837
Countries citing papers authored by U. Gatzemeier
This map shows the geographic impact of U. Gatzemeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Gatzemeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Gatzemeier more than expected).
Fields of papers citing papers by U. Gatzemeier
This network shows the impact of papers produced by U. Gatzemeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Gatzemeier. The network helps show where U. Gatzemeier may publish in the future.
Co-authorship network of co-authors of U. Gatzemeier
This figure shows the co-authorship network connecting the top 25 collaborators of U. Gatzemeier. A scholar is included among the top collaborators of U. Gatzemeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Gatzemeier. U. Gatzemeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 38 | |
| 3 | 56 | |
| 4 | 63 | |
| 5 | Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancerbreakdown → | 2487 |
| 6 | 9 | |
| 7 | 0 | |
| 8 | 94 | |
| 9 | 17 | |
| 10 | 8 | |
| 11 | 219 | |
| 12 | 25 | |
| 13 | Etude multicentrique de phase II de la gemcitabine dans les cancers bronchiques non à petites cellules (CBNPC) | 1 |
| 14 | 14 | |
| 15 | 7 | |
| 16 | 425 | |
| 17 | 17 | |
| 18 | 12 | |
| 19 | 15 | |
| 20 | 5 |
About U. Gatzemeier
U. Gatzemeier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 184 papers that have together received 16.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (113 papers), Lung Cancer Research Studies (87 papers) and Cancer therapeutics and mechanisms (43 papers). The work is most often cited by research in Oncology (10.7k citations), Pulmonary and Respiratory Medicine (12.3k citations) and Cancer Research (1.8k citations). U. Gatzemeier has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Joachim von Pawel, Christian Manegold, E. Kaukel, Paolo Paoletti, Filippo de Marinis, Giorgio V. Scagliotti, Claude Denham, Clet Niyikiza, James T. Symanowski and James J. Rusthoven. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.